Who founded Psycheceutical?

Psycheceutical was founded by Neilank K. Jha in 2020.

How much funding has Psycheceutical raised?

Psycheceutical has disclosed $405K raised across 1 of its 2 known rounds.

Where is Psycheceutical headquartered?

Psycheceutical is headquartered in Fort Lauderdale, US.

Psycheceutical

Fort Lauderdale, US · Founded 2020 · Florida corporation · 1 known investors

Find your way into Psycheceutical

Paths you didn't know you had: your email and LinkedIn already hold routes to the Psycheceutical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PsycheCeutical is a pharmaceutical company developing drug treatments related to brain injury, mental health, and neurological conditions such as traumatic brain injury, PTSD, and post-concussion syndrome. Its team combines neurosurgeons, neurologists, and pharmaceutical development specialists focused on therapeutics linking mental and physical health.

Biotech Digital Health Healthtech Mental Health

Founders & leadership

Psycheceutical was founded in 2020 by Neilank K. Jha.

Neilank K. Jha Neilank K. Jha holds an MD and MSc, is a Fellow of the Royal College of Surgeons of Canada, and has an MBA. He has worked across medicine, corporate restructuring, finance, law, regulatory affairs, and intellectual property before becoming CEO of PsycheCeutical.

Michael Hlavsa Michael Hlavsa holds certifications as a Certified Public Accountant, Certified Internal Auditor, and Chartered Global Management Accountant, and has worked in gaming before co-founding PsycheCeutical, which develops pharmaceutical treatments for traumatic brain injury, PTSD, and related neurological conditions.

Chad HarmanNamed on SEC filing

Investors · 1

Also in the syndicate · 1

Cantheon Capitallead

Reported raises · per SEC filings

Form D private placements

$405K disclosed across 1 of 2 rounds · 2021–2023

▶$405KraisedOct 2021 · 8 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Chad HarmanExecutive Officer

Offering amount: $2M
Amount sold: $405K
Minimum investment: $25K
First sale: Sep 2021
Incorporated: Corporation, Florida, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing - Psycheceutical, Incpsycheceutical.com · Nov 2023

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD - Psycheceutical, Incpsycheceutical.com · Jun 2023

Frequently asked questions

What does Psycheceutical do?: PsycheCeutical is a pharmaceutical company developing drug treatments related to brain injury, mental health, and neurological conditions such as traumatic brain injury, PTSD, and post-concussion syndrome. Its team combines neurosurgeons, neurologists, and pharmaceutical development specialists focused on therapeutics linking mental and physical health.
Who founded Psycheceutical?: Psycheceutical was founded by Neilank K. Jha in 2020.
How much funding has Psycheceutical raised?: Psycheceutical has disclosed $405K raised across 1 of its 2 known rounds.
Where is Psycheceutical headquartered?: Psycheceutical is headquartered in Fort Lauderdale, US.